Ignite Creation Date:
2025-12-24 @ 3:46 PM
Ignite Modification Date:
2025-12-29 @ 4:41 PM
Study NCT ID:
NCT00500292
Status:
COMPLETED
Last Update Posted:
2018-01-25
First Post:
2007-07-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer
Sponsor:
Genzyme, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
2008-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-03
First Submit QC Date:
None
Study First Post Date:
2007-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-04-27
Results First Submit QC Date:
None
Results First Post Date:
2011-05-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-24
Last Update Post Date:
2018-01-25
Last Update Post Date Type:
ACTUAL